| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 108.09B | 112.34B | 105.71B | 102.47B | 95.23B | 88.51B |
| Gross Profit | 31.37B | 33.61B | 30.66B | 29.92B | 27.18B | 24.13B |
| EBITDA | 7.22B | 8.91B | 7.80B | 8.03B | 6.32B | 3.53B |
| Net Income | 3.49B | 4.46B | 3.51B | 3.69B | 2.56B | 720.00M |
Balance Sheet | ||||||
| Total Assets | 93.68B | 99.64B | 95.76B | 92.61B | 85.87B | 80.92B |
| Cash, Cash Equivalents and Short-Term Investments | 9.37B | 10.11B | 8.21B | 9.63B | 9.74B | 10.34B |
| Total Debt | 10.78B | 10.18B | 10.62B | 6.79B | 6.70B | 7.09B |
| Total Liabilities | 45.95B | 47.45B | 47.38B | 46.84B | 44.97B | 42.63B |
| Stockholders Equity | 47.39B | 51.81B | 48.05B | 45.43B | 40.61B | 38.01B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.15B | -2.65B | 1.61B | 391.00M | 1.29B |
| Operating Cash Flow | 0.00 | 9.12B | 2.47B | 5.29B | 3.60B | 4.96B |
| Investing Cash Flow | 0.00 | -4.35B | -4.77B | -3.90B | -3.27B | -4.02B |
| Financing Cash Flow | 0.00 | -2.86B | 842.00M | -1.57B | -934.00M | -1.06B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥9.19B | 8.45 | ― | 3.73% | 3.14% | 7744.43% | |
73 Outperform | ¥42.46B | 8.17 | ― | 3.74% | 4.73% | 17.57% | |
71 Outperform | ¥31.93B | 8.57 | ― | 3.59% | 6.27% | 28.43% | |
68 Neutral | ¥123.53B | 10.61 | 12.89% | 3.40% | 3.44% | -3.09% | |
68 Neutral | ¥5.62B | 7.04 | ― | 4.13% | 2.80% | 4.60% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
55 Neutral | ¥98.42B | 43.49 | ― | 3.53% | -3.19% | -4.14% |